S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The “Perfect Storm” for Gold (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Options trading has suddenly become more reliable. (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The “Perfect Storm” for Gold (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Options trading has suddenly become more reliable. (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The “Perfect Storm” for Gold (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Options trading has suddenly become more reliable. (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The “Perfect Storm” for Gold (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Options trading has suddenly become more reliable. (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Free Trial
NASDAQ:EDGE

Edge Therapeutics (EDGE) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)
Free EDGE Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$2.59
▼
$2.92
50-Day Range
$0.50
▼
$6.71
52-Week Range
$0.28
▼
$17.38
Volume
881,240 shs
Average Volume
373,201 shs
Market Capitalization
$83.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisCompetitorsHeadlinesSocial Media
EDGE stock logo

About Edge Therapeutics Stock (NASDAQ:EDGE)

PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo on March 15, 2019 and is headquartered in Princeton, NJ.

EDGE Stock News Headlines

April 19, 2024 | finance.yahoo.com
Peptide Therapeutics Market Projected to Reach $57.97 billion by 2030 - Exclusive Report by 360iResearch
April 18, 2024 | markets.businessinsider.com
Maintaining the Edge: Argenx’s Hold Rating Amidst Rising Competition and Promising Therapy Results
April 19, 2024 | Crypto 101 Media (Ad)
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
April 18, 2024 | finance.yahoo.com
Panasonic and Shinobi Therapeutics Partner to Develop Efficient and Cost-Effective iPS Cell Therapy Manufacturing Technology
April 15, 2024 | finance.yahoo.com
Myeloid Therapeutics to Participate in Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
April 15, 2024 | finance.yahoo.com
Gastrointestinal Therapeutics and Diagnostics: Propelling Global Markets with Cutting-Edge Technologies by BCC Research LLC
April 14, 2024 | msn.com
How cutting-edge therapies—like Ozempic—are changing the drug-pricing landscape
April 11, 2024 | msn.com
Prelude Therapeutics Unveils Promising Cancer Treatment Advances at AACR Meeting
April 19, 2024 | Crypto 101 Media (Ad)
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
April 4, 2024 | seekingalpha.com
Buy Vafseo's Approval: A New Chapter For Akebia Therapeutics In Anemia Management
April 4, 2024 | finance.yahoo.com
Myeloid Therapeutics to Showcase In Vivo CAR Data and its Diverse mRNA Platform at AACR
April 3, 2024 | benzinga.com
US Stocks Edge Lower; Private Employment Tops Views
April 3, 2024 | msn.com
Neighbors on edge after dog owner dead blocks away from Washington Avenue: 'Honestly kind of scared'
April 2, 2024 | finance.yahoo.com
Accelerating New Molecule Discovery: Rakovina Therapeutics AI Integration
April 2, 2024 | sg.finance.yahoo.com
UPDATE 1-Verve Therapeutics pauses enrollment in early-stage gene therapy study for high cholesterol levels
April 1, 2024 | marketwatch.com
Toronto Stocks Edge Lower; Ballard Power Rises on Fuel-Cell Order
April 1, 2024 | finance.yahoo.com
GPCR Therapeutics Announces Publication in PNAS Using Cutting Edge Spectroscopy to Detect GPCR Heteromers on Live Cancer Cells
March 30, 2024 | seekingalpha.com
Crispr Therapeutics: Upcoming Catalysts May Validate The Bull Thesis And Force A Change In Plans
March 28, 2024 | uk.finance.yahoo.com
Global Metastatic Melanoma Therapeutics Market Anticipates Robust Growth with New Therapeutic Developments
March 27, 2024 | finance.yahoo.com
Is Indaptus Therapeutics (NASDAQ:INDP) In A Good Position To Invest In Growth?
March 27, 2024 | finance.yahoo.com
Companies Like Context Therapeutics (NASDAQ:CNTX) Could Be Quite Risky
March 22, 2024 | au.finance.yahoo.com
Q4 2023 Mink Therapeutics Inc Earnings Call
March 21, 2024 | finance.yahoo.com
Mirador Therapeutics Launches to Accelerate the Next Generation of Precision Medicines for Immune-mediated Diseases
March 20, 2024 | finanznachrichten.de
Phaxiam Therapeutics S.A.: PHAXIAM Announces 2023 Full-Year Results and Provides Business Update
March 19, 2024 | finance.yahoo.com
Tempo Therapeutics Secures Series A Financing to Advance Cutting-Edge Tissue Scaffold Products into Clinical Trials
March 19, 2024 | seekingalpha.com
Contineum Therapeutics Seeks $150 Million IPO For MS Treatments
March 19, 2024 | finanznachrichten.de
Telum Therapeutics appoints Dr. Subhendu Basu as CEO
See More Headlines
Receive EDGE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Edge Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/01/2018
Today
4/19/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:EDGE
CUSIP
N/A
CIK
1472091
Web
www.edgetherapeutics.com
Phone
(800) 208-3343
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-40,860,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-81.29%
Return on Assets
-56.92%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.59
Quick Ratio
5.59

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.95 per share
Price / Book
3.05

Miscellaneous

Outstanding Shares
31,510,000
Free Float
N/A
Market Cap
$91.38 million
Optionable
Not Optionable
Beta
3.65
5G Stocks: The Path Forward is Profitable Cover
5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Frank K. Bedu-Addo
    President, Chief Executive Officer & Director
  • Michael P. King
    Chief Financial Officer
  • Lauren Wood
    Chief Medical Officer
  • Gregory L. Conn
    Chief Scientific Officer
  • Janetta Trochimiuk
    Controller

Key Competitors

View All Competitors

EDGE Stock Analysis - Frequently Asked Questions

How were Edge Therapeutics' earnings last quarter?

Edge Therapeutics, Inc. (NASDAQ:EDGE) released its earnings results on Thursday, November, 1st. The biotechnology company reported ($0.11) earnings per share for the quarter, topping the consensus estimate of ($0.27) by $0.16.

What other stocks do shareholders of Edge Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Edge Therapeutics investors own include ContraFect (CFRX), Amicus Therapeutics (FOLD), McEwen Mining (MUX), Cerecor (CERC), Synergy Pharmaceuticals (SGYP), Arena Pharmaceuticals (ARNA), BioLineRx (BLRX), Corbus Pharmaceuticals (CRBP), CRISPR Therapeutics (CRSP) and Fate Therapeutics (FATE).

This page (NASDAQ:EDGE) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
SHOCKING Crypto Leak…
Crypto 101 Media
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
Options trading has suddenly become more reliable.
Eagle Publishing
How Biden has already won 2024
Porter & Company
Top 5 AI Stocks to Buy for 2024
Market Moving Trends